Literature DB >> 12885336

Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews.

Ofer Lehavi1, Orna Aizenstein, Dani Bercovich, Dina Pavzner, Ruth Shomrat, Avi Orr-Urtreger, Yuval Yaron.   

Abstract

Familial dysautonomia (FD) is an autosomal recessive disorder characterized by hereditary sensory and autonomic neuropathies. Although extremely rare in most populations, FD is common among Ashkenazi Jews (AJ), with a calculated carrier frequency of 1 in 30, based on disease prevalence. The gene for FD was recently identified as IKBKAP. One major mutation (IVS2 + 6T --> C) is responsible in >99.5% of cases among AJ. The purpose of this study was to determine the actual frequency of FD carriers in the AJ population in Israel and to determine whether carriers are more frequent among a subpopulation of AJ from Poland. The study group included 1267 Jews of Ashkenazi origin who were referred for routine DNA screening tests. These included 1100 individuals who were full AJ and 167 who were part AJ. None had a family history of FD. Mutation analysis for (IVS2 + 6T --> C) was performed by PCR amplification followed by restriction enzyme analysis. All positive cases were confirmed by DHPLC WAVE( trade mark ). Among the 1100 full AJ tested, 34 were found to be FD carriers (1:32). The incidence of mutation carriers was significantly higher in AJ of Polish descent (1:18) compared to AJ of non-Polish descent (1:99). Among the 167 individuals who were part AJ, there were 3 carriers (1:56). The incidence of FD among AJ, particularly those of Polish background, warrants population screening. Population screening may be performed by denaturing high-performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885336     DOI: 10.1089/109065703322146830

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  20 in total

Review 1.  Hereditary Sensory and Autonomic Neuropathies: Adding More to the Classification.

Authors:  Coreen Schwartzlow; Mohamed Kazamel
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-20       Impact factor: 5.081

2.  Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia.

Authors:  Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt
Journal:  J Mol Med (Berl)       Date:  2007-01-06       Impact factor: 4.599

3.  Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.

Authors:  Stuart A Scott; Lisa Edelmann; Liu Liu; Minjie Luo; Robert J Desnick; Ruth Kornreich
Journal:  Hum Mutat       Date:  2010-11       Impact factor: 4.878

4.  Specific correction of a splice defect in brain by nutritional supplementation.

Authors:  Ranjit S Shetty; Cary S Gallagher; Yei-Tsung Chen; Matthew M Hims; James Mull; Maire Leyne; James Pickel; David Kwok; Susan A Slaugenhaupt
Journal:  Hum Mol Genet       Date:  2011-08-05       Impact factor: 6.150

Review 5.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

6.  Echocardiographic abnormalities in familial dysautonomia.

Authors:  Udi Nussinovitch; Uriel Katz; Moshe Nussinovitch; Leonard Blieden; Naomi Nussinovitch
Journal:  Pediatr Cardiol       Date:  2009-07-30       Impact factor: 1.655

7.  Late ventricular potentials and QT dispersion in familial dysautonomia.

Authors:  Udi Nussinovitch; Uriel Katz; Moshe Nussinovitch; Naomi Nussinovitch
Journal:  Pediatr Cardiol       Date:  2009-04-02       Impact factor: 1.655

8.  Loss of mouse Ikbkap, a subunit of elongator, leads to transcriptional deficits and embryonic lethality that can be rescued by human IKBKAP.

Authors:  Yei-Tsung Chen; Matthew M Hims; Ranjit S Shetty; James Mull; Lijuan Liu; Maire Leyne; Susan A Slaugenhaupt
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

9.  A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.

Authors:  Matthew M Hims; Ranjit S Shetty; James Pickel; James Mull; Maire Leyne; Lijuan Liu; James F Gusella; Susan A Slaugenhaupt
Journal:  Genomics       Date:  2007-07-17       Impact factor: 5.736

10.  A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation.

Authors:  Marisa Z Jackson; Katherine A Gruner; Charles Qin; Warren G Tourtellotte
Journal:  Development       Date:  2014-06       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.